vVARDIS Holding AG priced its initial public offering at US$18.00 per Class A ordinary share. The offering covers 9,722,223 Class A ordinary shares. Shares are expected to begin trading on the New York Stock Exchange on November 13, 2026 under the symbol VVVV.
Offering details
The underwriters have a 30-day option to buy up to 1,458,333 additional Class A ordinary shares. Goldman Sachs & Co. LLC and J.P. Morgan are joint bookrunning managers. William Blair, UBS Investment Bank, and Deutsche Bank Securities act as bookrunners.
Company background
vVARDIS is headquartered in Zug, Switzerland. It operates in the dental med-tech sector. The company offers dental products under the Curodont brand.
Product focus
Curodont products target dental professionals. They provide non-invasive options for cavity treatment. The company says its mission is to make cavity treatment drill-free, regenerative, and accessible to all.
The offering is expected to close around November 16, 2026, subject to customary closing conditions. The registration statement became effective on November 12, 2026. Copies of the final prospectus may be obtained from the SEC website and the underwriters.